leadf
logo-loader
viewMarrone Bio Innovations

Marrone Bio Innovations sets August 3 start date for new CEO Kevin Helash; plans 2Q conference call

Helash comes to Marrone Bio from Agrinos AS, a global-scale biological crop input provider specializing in biofertilizers

Boardroom with three people
Marrone Bio holds more than 400 issued and pending patents and has brought six EPA-registered biological product lines and one biostimulant to market

Marrone Bio Innovations Inc (NASDAQ:MBII) announced Friday that incoming CEO Kevin Helash will officially take the reins on August 3, a week before the company reports its second-quarter results. 

The plant health solutions company's management, including Helash, plans to host an investor conference call at 4.30 pm ET (1.30 pm PT) on August 10 to reveal the results for the three months ended June 30, 2020. Registration can be done here.

“I am excited to join the team at Marrone Bio, and look forward to discussing the second quarter financial results with our shareholders on the August 10th conference call,” Helash said in a statement.

READ: Marrone Bio appoints agricultural industry veteran Kevin Helash as CEO

Helash will also join Marrone Bio’s board of directors on August 3.

A 28-plus-year agricultural industry veteran, Helash comes to Marrone Bio from Agrinos AS, a global-scale biological crop input provider specializing in biofertilizers and biostimulant products. As CEO of Agrinos since November 2017, he led a major restructuring and transformation of the company to create a platform for future long-term growth.

Helash replaces Pamela Marrone, founder of Marrone Bio, who announced her intention to retire as CEO in December 2019.

Based in Davis, California, Marrone Bio holds more than 400 issued and pending patents and has brought six US Environmental Protection Agency-registered biological product lines and one biostimulant to market. 

Contact Andrew Kessel at andrew.kessel@proactiveinvestors.com

Follow him on Twitter @andrew_kessel

Quick facts: Marrone Bio Innovations

Price: 1.18 USD

NASDAQ:MBII
Market: NASDAQ
Market Cap: $176.26 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Marrone Bio Innovations named herein, including the promotion by the Company of Marrone Bio Innovations in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Marrone Bio Innovations announces alliance with South American company...

Marrone Bio Innovations (NASDAQ: MBII) Chief Commerical Officer Kevin Hammill joined Steve Darling from Proactive to share news the company has taken a step forward on global expansion by announcing an alliance with the South American company Rizobacter to distribute novel plant health and crop...

7 hours, 5 minutes ago

2 min read